0
USD
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Non Invasive Prenatal Testing (NIPT) Market Outlook 2024: China Opportunity and Demand Analysis, Market Forecast 2017 to 2024
Published Date: February 2019
|
Report Code: DPIR-Diag-31
Home | Market Reports |Health |Reproductive Health
China Non Invasive Prenatal Testing Market 2017 to 2024

Non Invasive Prenatal Testing (NIPT) Market Outlook 2024: China Opportunity and Demand Analysis, Market Forecast 2017 to 2024

Code: DPIR-Diag-31
Report
February 2019
55 Pages
DPI Research
Region: Asia Pacific,
Description
Table of Content
Tables & Figures

China Potential Non–Invasive Prenatal Testing (NIPT) market is likely to reach more than US$ 1.7 Billion by 2024.

Long–term Growth Projection and Development:

• It is predicted that China Actual NIPT test volume will increase to 1.6 Million by 2024
• More than 3,00,000 NIFTY tests done in 2016
• Berry Genomics completes US$ 648 Million reverse merger in Shenzhen
• Two–Child policy is likely to boost China NIPT market

Growth in China NIPT market can be attributed to factors such as high incidence rate of babies born with Down syndrome, no risk of miscarriage with NIPT and shifting trend towards child bearing at advanced maternal age (35 years or older). High test cost, strict regulatory requirements and ethical hurdles is restraining the growth of China NIPT market. Due to expanding patient access to NIPT test, the China NIPT test market is poised to have a positive outlook in the year ahead.

The research report titled “Non–Invasive Prenatal Testing(NIPT) Market Outlook 2024: China Opportunity and Demand Analysis, Market Forecast 2017–2024” examines the market dynamics, competitive landscape and discusses major trends. The study describes an in–depth analysis of the China actual and potential NIPT market.

The report contains a granular analysis of the market segmentation, reveal facts on the market size, volume and revenues; and provides forecasts through 2024. It also includes a snapshot of the NIPT implementation in the low and middle-income countries. The report also explores detailed description of growth drivers and inhibitors of the China NIPT Market.

The report concludes with the profiles of major players in the China NIPT Market. The key market players are evaluated on various parameters such as company introduction, NIPT test portfolio, NIPT test analysis with volume and market revenue and latest development/updates of the NIPT Market in China.

Key Topics Covered in the Report

• 2013 - 2024: China Potential NIPT Test Market Size & Analysis (Volume and Value)
• 2013 - 2024: China Actual NIPT Test Market Size & Analysis (Volume and Value)
• NIPT Test Implementation in Low & Middle–Income Countries
• Key Companies Analysis
• Key Drivers and Inhibitors of the China NIPT Test Market

Key Companies Covered in the Report are as follows:

• Berry Genomics
• BGI Diagnosis Co., Ltd
• Basetra

1. Executive Summary

2. Market Size & Analysis: China Potential NIPT Test (Volume and Value)
2.1 Potential NIPT Test Volume (2013 – 2024)
2.2 Potential NIPT Test Market (2013 – 2024)

3. Market Size & Analysis: China Actual NIPT Test (Volume and Value)
3.1 Actual NIPT Test Volume (2013 – 2024)
3.2 Actual NIPT Test Market (2013 – 2024)

4. Key Drivers and Inhibitors of the China NIPT Market
4.1 Market Drivers
4.2 Market Inhibitors

5. Non–Invasive Prenatal Testing (NIPT) Implementation – Low & Middle–Income Countries

6. China NIPT Key Players: Company Profiles
6.1 BGI Diagnosis Co., Ltd
6.1.1 Company Introduction
6.1.2 Product Portfolio
6.1.2.1 NIFTY Test
6.1.3 NIPT Test Analysis (Volume and Value)
6.1.3.1 Overall NIPT Test Volume & Forecast
6.1.3.2 Overall NIPT Test Market Revenue & Forecast
6.1.4 Latest Development/Updates
6.2 Berry Genomics
6.2.1 Company Introduction
6.2.2 Product Portfolio
6.2.2.1 Bambni Test
6.2.3 NIPT Test Analysis (Volume and Value)
6.2.3.1 Overall NIPT Test Volume & Forecast
6.2.3.2 Overall NIPT Test Market Revenue & Forecast
6.2.4 Latest Development/Updates
6.3 Basetra
6.3.1 Company Introduction
6.3.2 Product Portfolio
6.3.2.1 Babyguard

Figure 2–1: China – Potential NIPT Test Volume (Million),2013 – 2016
Figure 2–2: China – Forecast for Potential NIPT Test Volume (Million),2017 – 2024
Figure 2–3: China – Potential NIPT Test Market (Million US$),2013 – 2016
Figure 2–4: China – Forecast for Potential NIPT Test Market (Million US$),2017 – 2024
Figure 3–1: China – Actual NIPT Test Volume (Number),2013 – 2016
Figure 3–2: China – Forecast for Actual NIPT Test Volume (Number),2017 – 2024
Figure 3–3: China – Actual NIPT Test Market (Million US$),2013 – 2016
Figure 3–4: China – Forecast for Actual NIPT Test Market (Million US$),2017 – 2024
Figure 6–1: Overall NIFTY Test Volume (Number), 2012 – 2016
Figure 6–2: Overall – Forecast for NIFTY Test Volume (Number), 2017 – 2024
Figure 6–3: Overall – NIFTY Test Market Revenue (Million US$), 2012 – 2016
Figure 6–4: Overall – Forecast for NIFTY Test Market Revenue (Million US$), 2017 – 2024
Figure 6–5: Overall – Bambini Test Volume (Number), 2012 – 2016
Figure 6–6: Overall – Forecast for Bambini Test Volume (Number), 2017 – 2024
Figure 6–7: Overall – Bambini Test Market Revenue (Million US$), 2012 – 2016
Figure 6–8: Overall – Forecast for Bambini Test Market Revenue (Million US$), 2017 – 2024

China Potential Non–Invasive Prenatal Testing (NIPT) market is likely to reach more than US$ 1.7 Billion by 2024.

Long–term Growth Projection and Development:

• It is predicted that China Actual NIPT test volume will increase to 1.6 Million by 2024
• More than 3,00,000 NIFTY tests done in 2016
• Berry Genomics completes US$ 648 Million reverse merger in Shenzhen
• Two–Child policy is likely to boost China NIPT market

Growth in China NIPT market can be attributed to factors such as high incidence rate of babies born with Down syndrome, no risk of miscarriage with NIPT and shifting trend towards child bearing at advanced maternal age (35 years or older). High test cost, strict regulatory requirements and ethical hurdles is restraining the growth of China NIPT market. Due to expanding patient access to NIPT test, the China NIPT test market is poised to have a positive outlook in the year ahead.

The research report titled “Non–Invasive Prenatal Testing(NIPT) Market Outlook 2024: China Opportunity and Demand Analysis, Market Forecast 2017–2024” examines the market dynamics, competitive landscape and discusses major trends. The study describes an in–depth analysis of the China actual and potential NIPT market.

The report contains a granular analysis of the market segmentation, reveal facts on the market size, volume and revenues; and provides forecasts through 2024. It also includes a snapshot of the NIPT implementation in the low and middle-income countries. The report also explores detailed description of growth drivers and inhibitors of the China NIPT Market.

The report concludes with the profiles of major players in the China NIPT Market. The key market players are evaluated on various parameters such as company introduction, NIPT test portfolio, NIPT test analysis with volume and market revenue and latest development/updates of the NIPT Market in China.

Key Topics Covered in the Report

• 2013 - 2024: China Potential NIPT Test Market Size & Analysis (Volume and Value)
• 2013 - 2024: China Actual NIPT Test Market Size & Analysis (Volume and Value)
• NIPT Test Implementation in Low & Middle–Income Countries
• Key Companies Analysis
• Key Drivers and Inhibitors of the China NIPT Test Market

Key Companies Covered in the Report are as follows:

• Berry Genomics
• BGI Diagnosis Co., Ltd
• Basetra

Read More

1. Executive Summary

2. Market Size & Analysis: China Potential NIPT Test (Volume and Value)
2.1 Potential NIPT Test Volume (2013 – 2024)
2.2 Potential NIPT Test Market (2013 – 2024)

3. Market Size & Analysis: China Actual NIPT Test (Volume and Value)
3.1 Actual NIPT Test Volume (2013 – 2024)
3.2 Actual NIPT Test Market (2013 – 2024)

4. Key Drivers and Inhibitors of the China NIPT Market
4.1 Market Drivers
4.2 Market Inhibitors

5. Non–Invasive Prenatal Testing (NIPT) Implementation – Low & Middle–Income Countries

6. China NIPT Key Players: Company Profiles
6.1 BGI Diagnosis Co., Ltd
6.1.1 Company Introduction
6.1.2 Product Portfolio
6.1.2.1 NIFTY Test
6.1.3 NIPT Test Analysis (Volume and Value)
6.1.3.1 Overall NIPT Test Volume & Forecast
6.1.3.2 Overall NIPT Test Market Revenue & Forecast
6.1.4 Latest Development/Updates
6.2 Berry Genomics
6.2.1 Company Introduction
6.2.2 Product Portfolio
6.2.2.1 Bambni Test
6.2.3 NIPT Test Analysis (Volume and Value)
6.2.3.1 Overall NIPT Test Volume & Forecast
6.2.3.2 Overall NIPT Test Market Revenue & Forecast
6.2.4 Latest Development/Updates
6.3 Basetra
6.3.1 Company Introduction
6.3.2 Product Portfolio
6.3.2.1 Babyguard

Read More

Figure 2–1: China – Potential NIPT Test Volume (Million),2013 – 2016
Figure 2–2: China – Forecast for Potential NIPT Test Volume (Million),2017 – 2024
Figure 2–3: China – Potential NIPT Test Market (Million US$),2013 – 2016
Figure 2–4: China – Forecast for Potential NIPT Test Market (Million US$),2017 – 2024
Figure 3–1: China – Actual NIPT Test Volume (Number),2013 – 2016
Figure 3–2: China – Forecast for Actual NIPT Test Volume (Number),2017 – 2024
Figure 3–3: China – Actual NIPT Test Market (Million US$),2013 – 2016
Figure 3–4: China – Forecast for Actual NIPT Test Market (Million US$),2017 – 2024
Figure 6–1: Overall NIFTY Test Volume (Number), 2012 – 2016
Figure 6–2: Overall – Forecast for NIFTY Test Volume (Number), 2017 – 2024
Figure 6–3: Overall – NIFTY Test Market Revenue (Million US$), 2012 – 2016
Figure 6–4: Overall – Forecast for NIFTY Test Market Revenue (Million US$), 2017 – 2024
Figure 6–5: Overall – Bambini Test Volume (Number), 2012 – 2016
Figure 6–6: Overall – Forecast for Bambini Test Volume (Number), 2017 – 2024
Figure 6–7: Overall – Bambini Test Market Revenue (Million US$), 2012 – 2016
Figure 6–8: Overall – Forecast for Bambini Test Market Revenue (Million US$), 2017 – 2024

Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$800
This license allows only one user to access the PDF.

Multi User

Electronic (PDF)
$1300
This license allows multiple user to access the PDF.

Corporate User

Electronic (PDF)
$1300
This license allows all the corporate employees to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SIS Group of Schools

RELATED REPORTS

Global Injectable Reproductive Hormone Sales Market Report 2021
Global Injectable Reproductive Hormone Sales Market Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-36M5188
Tue Jun 15 00:00:00 UTC 2021

Add to Cart

Global Bath Body Combo for Baby Sales Market Report 2021
Global Bath & Body Combo for Baby Sales Market Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-23D5011
Mon Jun 14 00:00:00 UTC 2021

Add to Cart

Global Levonorgestrel Market Insights and Forecast to 2027
Global Levonorgestrel Market Insights and Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-23S15
Mon Jun 14 00:00:00 UTC 2021

Add to Cart

Global Pelvic Organ Prolapse Devices Sales Market Report 2021
Global Pelvic Organ Prolapse Devices Sales Market Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-21A5110
Sun Jun 13 00:00:00 UTC 2021

Add to Cart

0 Items
X
No items in the cart.
$0.0